Commodore Capital LP

SEC CIK: 0001831942
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

RLMD holding history

Relmada Therapeutics, Inc. in every 13F filed by Commodore Capital LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RLMD overview All 13F holders of RLMD Full Q2 2026 holdings

Shares (Q2 2026): 1,425,000
Value: $9.86M
% of portfolio: 0.6%
Quarters held: 3; Since Q1 2021

Holdings of RLMD by Commodore Capital LP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	1,425,000	$9.86M	0.6%	+791,099+124.8%	Added	Holders
Q1 2026	633,901	$4.41M	0.3%	+633,901	New	Holders
Q2 2021	0	$0	0.0%	−161,565−100.0%	Sold out	Holders
Q1 2021	161,565	$5.69M	2.3%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.